CCS vs ECG
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
CCS
37.8
AI Score
VS
ECG Wins
ECG
55.5
AI Score
Investment Advisor Scores
ECG
56score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | CCS | ECG | Winner |
|---|---|---|---|
| Revenue | 2.58B | 3.65B | ECG |
| Net Income | 73.17M | 234.12M | ECG |
| Net Margin | 2.8% | 6.4% | ECG |
| ROE | 2.9% | 27.1% | ECG |
| ROA | 1.5% | 8.7% | ECG |
| Total Assets | 4.79B | 2.71B | CCS |
Relative Price Performance (Last 90 Days)
CCS 1M: -1.7%
· 3M: -23.2%
ECG 1M: -28.6%
· 3M: -38.8%
Current Technical Phase
CCS
MarkdownSell / avoid
Price below a falling SMA50 (slope -9.0%), weak momentum, RSI 44
ECG
MarkdownSell / avoid
Price below a falling SMA50 (slope -10.2%), weak momentum, RSI 39
Fundamentals Snapshot
| Metric | CCS | ECG |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 23.4 | 12.1 |
| Trailing P/E | 15.2 | 13.6 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.4% |
| Gross Margin | 0.2% | 0.1% |
| Operating Margin | 0.0% | 0.1% |
| EPS | 3.75 | 6.23 |
| Dividend Yield | 0.02% | — |
Frequently Asked Questions
Based on our detailed analysis, ECG is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.